Mr Michael James Mccarver, RPH | |
1010 W Columbia St, Farmington, MO 63640-2902 | |
(573) 218-6754 | |
(573) 218-6762 |
Full Name | Mr Michael James Mccarver |
---|---|
Gender | Male |
Speciality | Pharmacist - Psychiatric |
Location | 1010 W Columbia St, Farmington, Missouri |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114909801 | NPI | - | NPPES |
040731 | Other | MO | PHARMACIST LICENSE # |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1835P1300X | Pharmacist - Psychiatric | 040731 (Missouri) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Michael James Mccarver, RPH 1010 W Columbia St, Farmington, MO 63640-2902 Ph: (573) 218-6754 | Mr Michael James Mccarver, RPH 1010 W Columbia St, Farmington, MO 63640-2902 Ph: (573) 218-6754 |
News Archive
Carefx Corporation, a leading provider of interoperable workflow solutions, and Imprivata®, Inc., the employee access management company, today announced that Johns Hopkins Health System, an internationally recognized group of healthcare institutions, has selected Carefx Fusionfx and Imprivata OneSign to deliver an integrated clinical access solution that streamlines access to workstations, applications and patient data. The complete, integrated system will launch in early 2010.
Electronic tools and technology applications for consumers can help improve health care processes, such as adherence to medication and clinical outcomes like smoking cessation, according to a report by researchers at the Johns Hopkins Bloomberg School of Public Health.
President Barack Obama named University of Missouri researcher M. Frederick Hawthorne as recipient of the National Medal of Science, the highest honor bestowed by the country to scientists. Hawthorne is the director of the International Institute of Nano and Molecular Medicine at the University of Missouri, as well as Curators' Distinguished Professor of Chemistry and Radiology.
Myriad Genetics, Inc. (NASDAQ: MYGN) has announced that it has signed a three-year contract with Tufts Health Plan through which the plan will provide coverage of Prolaris® for members diagnosed with localized prostate cancer. Prolaris is the first and only biopsy test validated against prostate cancer specific mortality.
Immune responses to prevent or delay the spread of melanoma, a deadly form of skin cancer, are more likely to prolong survival in patients if their immune cells carry a special kind of marker on the surface, according to a team of researchers at the University of Virginia Health System.
› Verified 2 days ago
Michelle Lee Montgomery, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 E Karsch Blvd, Farmington, MO 63640 Phone: 573-701-0639 Fax: 573-701-0683 | |
Sony Sharp, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 600 W Karsch Blvd, Farmington, MO 63640 Phone: 573-747-1591 | |
Dr. Daniel Jaderko, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 E Karsch Blvd, Farmington, MO 63640 Phone: 573-701-0639 | |
Kimberly Herbst, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1101 Weber Rd, Farmington, MO 63640 Phone: 573-756-6117 | |
Shannon Beth Nelson-bryant, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 125 W Karsch Blvd, Farmington, MO 63640 Phone: 573-756-5425 | |
Mr. Gregory Joseph Rudroff, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 600 W Karsch Blvd, Farmington, MO 63640 Phone: 573-756-7861 |